The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
Open accessAbstract
As new disease threats arise and existing pathogens grow resistant to conventional interventions, attention increasingly focuses on the development of vaccines to induce protective immune responses. Given their admirable safety records, protein subunit vaccines are attractive for widespread immunization, but their disadvantages include poor immunogenicity and expensive manufacture. We show here that engineered Escherichia coli outer membrane vesicles (OMVs) are an easily purified vaccine-delivery system capable of greatly enhancing the immunogenicity of a low-immunogenicity protein antigen without added adjuvants. Using green-fluorescent protein (GFP) as the model subunit antigen, genetic fusion of GFP with the bacterial hemolysin ClyA resulted in a chimeric protein that elicited strong anti-GFP antibody titers in immunized mice, whereas immunization with GFP alone did not elicit such titers. Harnessing the specific secretion of ClyA to OMVs, the ClyA-GFP fusion was found localized in OMVs, resulting in engineered recombinant OMVs. The anti-GFP humoral response in mice immunized with the engineered OMV formulations was indistinguishable from the response to the purified ClyA-GFP fusion protein alone and equal to purified proteins absorbed to aluminum hydroxide, a standard adjuvant. In a major improvement over current practice, engineered OMVs containing ClyA-GFP were easily isolated by ultracentrifugation, effectively eliminating the need for laborious antigen purification from cell-culture expression systems. With the diverse collection of heterologous proteins that can be functionally localized with OMVs when fused with ClyA, this work signals the possibility of OMVs as a robust and tunable technology platform for a new generation of prophylactic and therapeutic vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FACS-optimized mutants of the green fluorescent protein (GFP)
Cormack, B. P., Valdivia, R. H., & Falkow, S. (1996) · Gene · doi:10.1016/0378-1119(95)00685-0 · Cited by 2,620
Structures of Gram-Negative Cell Walls and Their Derived Membrane Vesicles
Beveridge, T. J. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.16.4725-4733.1999 · Cited by 1,528
Bacterial outer membrane vesicles and the host–pathogen interaction
Kuehn, M. J., & Kesty, N. C. (2005) · Genes & Development · doi:10.1101/gad.1299905 · Cited by 951
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., & Osterhaus, A. (1984) · Nature · doi:10.1038/308457a0 · Cited by 708
Karkhanis, Y. D., Zeltner, J. Y., Jackson, J. J., & Carlo, D. J. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90260-9 · Cited by 704
(1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90281-5 · Cited by 671
Aluminum compounds as vaccine adjuvants
Gupta, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00008-8 · Cited by 623
Vesicle-Mediated Export and Assembly of Pore-Forming Oligomers of the Enterobacterial ClyA Cytotoxin
Wai, S. N., Lindmark, B., Söderblom, T., Takade, A., Westermark, M., Oscarsson, J., Jass, J., Richter-Dahlfors, A., Mizunoe, Y., & Uhlin, B. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00754-2 · Cited by 509
Recent advances in the discovery and delivery of vaccine adjuvants
O'Hagan, D. T., & Valiante, N. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1176 · Cited by 434
Escherichia coli tol-pal Mutants Form Outer Membrane Vesicles
Bernadac, A., Gavioli, M., Lazzaroni, J.-C., Raina, S., & Lloubès, R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.18.4872-4878.1998 · Cited by 385
Vaccine manufacturing: challenges and solutions
Ulmer, J. B., Valley, U., & Rappuoli, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1261 · Cited by 376
Alaniz, R. C., Deatherage, B. L., Lara, J. C., & Cookson, B. T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7692 · Cited by 321
Export of Virulence Genes and Shiga Toxin by Membrane Vesicles of Escherichia coli O157:H7
Kolling, G. L., & Matthews, K. R. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.5.1843-1848.1999 · Cited by 320
Bauman, S. J., & Kuehn, M. J. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.05.001 · Cited by 316
Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs
Felnerova, D., Viret, J.-F., Glück, R., & Moser, C. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.10.005 · Cited by 296
OSTER, P., LENNON, D., OHALLAHAN, J., MULHOLLAND, K., REID, S., & MARTIN, D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.063 · Cited by 271
Nanoparticles and microparticles as vaccine-delivery systems
Singh, M., Chakrapani, A., & O’Hagan, D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.797 · Cited by 259
Cell-Associated Ovalbumin Is Cross-Presented Much More Efficiently than Soluble Ovalbumin In Vivo
Li, M., Davey, G. M., Sutherland, R. M., Kurts, C., Lew, A. M., Hirst, C., Carbone, F. R., & Heath, W. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6099 · Cited by 251
Kesty, N. C., & Kuehn, M. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307628200 · Cited by 230
Engineered Bacterial Outer Membrane Vesicles with Enhanced Functionality
Kim, J.-Y., Doody, A. M., Chen, D. J., Cremona, G. H., Shuler, M. L., Putnam, D., & DeLisa, M. P. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.076 · Cited by 184
Self-citation(2004) · CRC Press eBooks · doi:10.1201/9781439834404 · Cited by 181
Lee, C.-H., & Tsai, C.-M. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.2961 · Cited by 175
Claassen, I., Meylis, J., van der Ley, P., Peeters, C., Brons, H., Robert, J., Borsboom, D., van der Ark, A., van Straaten, I., Roholl, P., et al. (1996) · Vaccine · doi:10.1016/0264-410x(96)00020-5 · Cited by 175
The Intangible Value of Vaccination
Rappuoli, R., Miller, H. I., & Falkow, S. (2002) · Science · doi:10.1126/science.1075173 · Cited by 163
de Kleijn, E. D., de Groot, R., Labadie, J., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00423-5 · Cited by 139
Wu, Y., Przysiecki, C. T., Flanagan, E., Bello‐Irizarry, S. N., Ionescu, R. M., Muratova, O. V., Dobrescu, G., Lambert, L., Keister, D. B., Rippeon, Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608545103 · Cited by 130
Lipid based particulate formulations for the delivery of antigen
Copland, M. J., Rades, T., Davies, N. M., & Baird, M. A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01315.x · Cited by 118
Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS Peptides
Lowell, G. H., Ballou, W. R., Smith, L. F., et al. (1988) · Science · doi:10.1126/science.2452484 · Cited by 114
Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines
Arigita, C., Jiskoot, W., Westdijk, J., van Ingen, C., Hennink, W. E., Crommelin, D. J. A., & Kersten, G. F. A. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.08.027 · Cited by 83
Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.
Lowell, G. H., Smith, L. F., Seid, R. C., et al. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.2.658 · Cited by 83
Eickhoff, T. C., & Myers, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00163-9 · Cited by 76
Galen, J. E., Zhao, L., Chinchilla, M., Wang, J. Y., Pasetti, M. F., Green, J. D., & Levine, M. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7096-7106.2004 · Cited by 71
Steeghs, L., Kuipers, B., Hamstra, H.-J., et al. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.4988-4993.1999 · Cited by 69
Vaccine Immunopotentiators of the Future
Schijns, V. E. J. C., & Degen, W. G. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100394 · Cited by 44
Secretion of the Escherichia coli K-12 SheA hemolysin is independent of its cytolytic activity
del Castillo, F. J. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00413-x · Cited by 20
Cited by
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Immune modulation by bacterial outer membrane vesicles
Kaparakis-Liaskos, M., & Ferrero, R. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3837 · Cited by 1,019
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Kim, O. Y., Park, H. T., Dinh, N. T. H., Choi, S. J., Lee, J., Kim, J. H., Lee, S.-W., & Gho, Y. S. (2017) · Nature Communications · doi:10.1038/s41467-017-00729-8 · Cited by 616
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
Needham, B. D., & Trent, M. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3047 · Cited by 565
Gujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
Metadata
- Authors
- Chen, D. J., Osterrieder, N., Metzger, S. M., Buckles, E., Doody, A. M., DeLisa, M. P., & Putnam, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-01-27
- Volume
- 107
- Issue
- 7
- Pages
- 3099-3104
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2050259218
- Cited by
- 302
- References
- 36
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.